FINNENCE▪
00:00:00 UTCSYS ONLINE
FINNENCE ▪ THE WIRE FILE

THE WIRE · № 68910

News▲ Bullish

Emerging Biotechs Standardize on Veeva Basics to Accelerate Drug Development

EXHIBIT · mmx.prnewswire.com
KINDNews
DIRECTION▲ Bullish
SOURCES2
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN2026-10-07 11:03 UTC
LAST UPDATE2026-10-07 11:03 UTC
STATEactive

01 THE MACHINE READ

WHY IT MATTERS.

Veeva expanding its customer base among emerging biotechs supports recurring software revenue.

Veeva deepens biotech software footprint
CATALYST TO WATCH

Customer count growth in future quarters

MAIN RISK

Small biotechs may cut software spend

FULL DISPATCH

More than 175 biotechs use pre-configured applications to streamline operations PLEASANTON, Calif., Oct. 7, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that more than 175 emerging biotechs are establishing a technology foundation with Veeva Basics. Biotechs are...

02 THE STORY SO FAR

THE RECORD, IN ORDER.

STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.

03 WHO'S INVOLVED

ENTITIES ON FILE.

AFFECTEDHealthcare

04 RECEIPTS

THE SOURCE RECORD.

2 SOURCES CONFIRMED
№ 01prnewswireprnewswire.com · CONFIRMING2026-10-07 11:03 UTCOPEN RECEIPT →
№ 02prnewswireprnewswire.com · PRIMARY2026-10-07 11:03 UTCOPEN RECEIPT →

05 PROPAGATION

WHAT THIS TOUCHES.

KEEP READING THE MACHINE

OPEN THE MACHINE →THE PREDICTION LEDGER →

Summaries are generated and may contain errors — every claim links its sources.